Mary Miller - Oct 17, 2024 Form 4 Insider Report for Acrivon Therapeutics, Inc. (ACRV)

Role
Chief Legal Officer
Signature
/s/ Rasmus Holm-Jorgensen, Attorney-in-Fact
Stock symbol
ACRV
Transactions as of
Oct 17, 2024
Transactions value $
-$4,391
Form type
4
Date filed
10/21/2024, 04:22 PM
Previous filing
Oct 3, 2024
Next filing
Nov 18, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACRV Common Stock Tax liability -$4.39K -558 -1.44% $7.87 38.1K Oct 17, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.